sr141716 has been researched along with Necrosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernardi, M; Caraceni, P; Croci, T; Cutrin, J; Domenicali, M; Giannone, F; Grattagliano, I; Mastroleo, C; Perrelli, MG; Pertosa, AM; Principe, A; Trevisani, F | 1 |
1 other study(ies) available for sr141716 and Necrosis
Article | Year |
---|---|
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.
Topics: Alanine Transaminase; Animals; Blood Pressure; Drug Evaluation, Preclinical; Endotoxemia; Lipopolysaccharides; Liver; Liver Circulation; Male; Necrosis; Neutrophil Infiltration; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant | 2009 |